This adaptation can manifest as an upregulation of anti-inflammatory factors by lung cancer cells to suppress surrounding immune cells, effectively maintaining an immunosuppressive tumor microenvironment while exploiting STING-driven inflammation to enhance invasiveness and metastasis 21, 59. The gene discussed is STING1; the disease is neoplasm.